Protection of human subjects with disability: guidelines for research

Area of Science:

• Medical Ethics
• Clinical Research
• Disability Studies

Background:

• Human subject protection in clinical research is a shared responsibility between Institutional Review Boards (IRBs) and principal investigators.
• IRBs assess protocol safety, ensuring risks are justified by potential benefits.
• Principal investigators are responsible for subject recruitment and obtaining informed consent.

Observation:

• Obtaining informed consent can be particularly challenging for individuals with significant developmental, physical, sensory, communicative, or cognitive disabilities.
• Rehabilitation medicine research increasingly involves populations with disabilities.
• Existing legal, ethical, and moral frameworks may not adequately address the complexities of informed consent for these individuals.

Findings:

• The process of informed consent requires investigators to ensure subjects fully understand proposed treatments, benefits, and risks.
• Current practices may present barriers to achieving truly informed consent for participants with disabilities.
• There is a need for tailored approaches to facilitate understanding and voluntary participation.

Implications:

• Enhanced strategies are necessary to protect the rights and welfare of individuals with disabilities participating in research.
• Recommendations are provided to improve the informed consent process for vulnerable populations in clinical and rehabilitation research.
• Ethical guidelines and legal frameworks should be reviewed and potentially updated to better serve diverse research participant groups.